Guardian Pharmacy Services (NYSE:GRDN) Hits New 52-Week High – Time to Buy?

Guardian Pharmacy Services, Inc. (NYSE:GRDN)’s stock price reached a new 52-week high during trading on Monday . The stock traded as high as $37.63 and last traded at $37.90, with a volume of 261565 shares trading hands. The stock had previously closed at $35.62.

Analyst Upgrades and Downgrades

GRDN has been the topic of several recent research reports. Oppenheimer raised their price target on Guardian Pharmacy Services from $35.00 to $38.00 and gave the stock an “outperform” rating in a report on Thursday, March 12th. Zacks Research upgraded Guardian Pharmacy Services from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, March 18th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Guardian Pharmacy Services in a research report on Monday, December 29th. UBS Group reiterated a “buy” rating on shares of Guardian Pharmacy Services in a research note on Thursday, March 12th. Finally, Stephens boosted their price target on shares of Guardian Pharmacy Services from $35.00 to $36.00 and gave the company an “overweight” rating in a report on Wednesday, January 14th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $38.00.

Guardian Pharmacy Services Stock Up 5.2%

The firm has a market capitalization of $2.37 billion, a price-to-earnings ratio of 48.65 and a beta of 0.85. The company has a 50-day moving average price of $32.25 and a 200-day moving average price of $29.70.

Guardian Pharmacy Services (NYSE:GRDN) last announced its quarterly earnings results on Wednesday, March 11th. The company reported $0.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.27 by $0.10. The company had revenue of $397.62 million during the quarter, compared to analyst estimates of $390.04 million. Guardian Pharmacy Services had a return on equity of 31.64% and a net margin of 3.40%.The company’s revenue for the quarter was up 17.4% compared to the same quarter last year. As a group, analysts forecast that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current year.

Hedge Funds Weigh In On Guardian Pharmacy Services

Large investors have recently bought and sold shares of the stock. Rakuten Investment Management Inc. bought a new stake in Guardian Pharmacy Services during the third quarter worth approximately $433,000. Geode Capital Management LLC boosted its stake in Guardian Pharmacy Services by 65.9% during the 2nd quarter. Geode Capital Management LLC now owns 336,701 shares of the company’s stock valued at $7,177,000 after purchasing an additional 133,715 shares in the last quarter. CSM Advisors LLC boosted its stake in Guardian Pharmacy Services by 40.9% during the 3rd quarter. CSM Advisors LLC now owns 135,665 shares of the company’s stock valued at $3,559,000 after purchasing an additional 39,360 shares in the last quarter. TimesSquare Capital Management LLC increased its position in shares of Guardian Pharmacy Services by 5.6% during the 3rd quarter. TimesSquare Capital Management LLC now owns 860,173 shares of the company’s stock valued at $22,562,000 after purchasing an additional 45,950 shares during the period. Finally, Aristotle Capital Boston LLC raised its stake in shares of Guardian Pharmacy Services by 58.5% in the 3rd quarter. Aristotle Capital Boston LLC now owns 649,463 shares of the company’s stock worth $17,035,000 after buying an additional 239,790 shares in the last quarter.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.